Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892917-96-000327
Filing Date
1996-12-30
Accepted
1996-12-30 00:00:00
Documents
13
Period of Report
1996-09-30
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT 10-K 315245
2 RESTATED BYLAWS EX-3.2 27658
3 LEASE EX-10.12 56890
4 AMENDMENT TO AGREEMENT EX-10.14 2830
5 OPERATING AGREEMENT EX-10.18 57440
6 DEVELOPMENT AND MARKETING AGREEMENT EX-10.19 49358
7 EMPLOYMENT AGREEMENT EX-10.28 27678
8 CREDIT AGREEMENT EX-10.29 98647
9 CONSENT OF INDEPENDENT ACCOUNTANTS EX-23.1 860
10 CONSENT OF INDEPENDENT ACCOUNTANTS EX-23.2 809
11 POWERS OF ATTORNEY EX-24 13177
12 FDS FOR ARTICLE 5 OF REGULATION S-X EX-27 2061
13 INDEPENDENT AUDITOR'S REPORT EX-99 1685
  Complete submission text file 0000892917-96-000327.txt   656987
Mailing Address 8505 S W CREEKSIDE PLACE BEAVERTON OR 97008
Business Address 8505 SW CREEKSIDE PL BEAVERTON OR 97005-7108 5036416115
EPITOPE INC/OR/ (Filer) CIK: 0000801555 (see all company filings)

EIN.: 930779127 | State of Incorp.: OR | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-10492 | Film No.: 96688257
SIC: 2835 In Vitro & In Vivo Diagnostic Substances